2185-0016 Screening compound: 2-{[1,1'-biphenyl]-4-yl}-6-[(2-{[1,1'-biphenyl]-4-yl}-3-phenylquinoxalin-6-yl)methyl]-3-phenylquinoxaline

2185-0016 Screening compound: 2-{[1,1'-biphenyl]-4-yl}-6-[(2-{[1,1'-biphenyl]-4-yl}-3-phenylquinoxalin-6-yl)methyl]-3-phenylquinoxaline
2185-0016 Screening compound: 2-{[1,1'-biphenyl]-4-yl}-6-[(2-{[1,1'-biphenyl]-4-yl}-3-phenylquinoxalin-6-yl)methyl]-3-phenylquinoxaline alternative view

Chemical Structure Depiction of ChemDiv screening compound 2185-0016
2-{[1,1'-biphenyl]-4-yl}-6-[(2-{[1,1'-biphenyl]-4-yl}-3-phenylquinoxalin-6-yl)methyl]-3-phenylquinoxaline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2185-0016

Molecular Formula

C53H36N4 (C53 H36 N4)

Compound Name

2-{[1,1'-biphenyl]-4-yl}-6-[(2-{[1,1'-biphenyl]-4-yl}-3-phenylquinoxalin-6-yl)methyl]-3-phenylquinoxaline

IUPAC name

2-{[11'-biphenyl]-4-yl}-6-[(2-{[11'-biphenyl]-4-yl}-3-phenylquinoxalin-6-yl)methyl]-3-phenylquinoxaline

SMILES

C(c1cc2nc(-c3ccccc3)c(-c(cc3)ccc3-c3ccccc3)nc2cc1)c1ccc2nc(-c(cc3)ccc3-c3ccccc3)c(-c3ccccc3)nc2c1

InChI

InChI=1S/C53H36N4/c1-5-13-38(14-6-1)40-23-27-44(28-24-40)52-50(42-17-9-3-10-18-42)56-48-34-36(21-31-46(48)54-52)33-37-22-32-47-49(35-37)57-51(43-19-11-4-12-20-43)53(55-47)45-29-25-41(26-30-45)39-15-7-2-8-16-39/h1-32,34-35H,33H2

InChI Key

QXNLFROEKISVKF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01017108

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

728.9

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

12.535

Distribution Coefficient, logD

12.535

Water Solubility, LogSw

-6.64

Polar Surface Area

35.285

Acid Dissociation Constant (pKa)

22.70

Base Dissociation Constant (pKb)

3.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

1.90

2185-0016 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Akt-Targeted Library (14764 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with 2185-0016 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2185-0016?
Check Price and Availability of 2185-0016, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2185-0016 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2185-0016
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2185-0016
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2185-0016 available by request